Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes

Table 2

Clinical characteristics of T2DM patients with vs. T2DM patients with .

			value
Male (%)	18 (72.0)	69 (62.2)	0.355
Diagnosis age (yrs)	42.5 (33.0-48.5)	42.0 (32.0-49.0)	0.838
Age (yrs)	56.0 (41.5-61.0)	53.0 (42.0-60.0)	0.548
Diabetes duration (yrs)	9.5 (4.0-14.3)	7.0 (2.0-14.0)	0.365
BMI (kg/m^2)	22.8 (21.2-25.4)	25.2 (23.5-28.0)	0.006
SBP (mmHg)	126 (120-140)	129 (120-138)	0.785
DBP (mmHg)	80 (70-80)	76 (68-80)	0.435
WL (cm)
Male	92 (79-98)	95 (88-98)	0.066
Female	83 (78-90)	89 (81-97)	0.370
TG (mmol/L)	1.28 (1.07-2.12)	1.55 (1.21-2.58)	0.111
TC (mmol/L)	4.81 (3.74-5.66)	4.40 (3.68-5.09)	0.064
HDL-c (mmol/L)
Male	1.03 (0.92-1.16)	0.96 (0.85-1.16)	0.812
Female	1.01 (0.73-1.20)	0.96 (0.81-1.14)	0.725
LDL-c (mmol/L)	2.81 (2.01-3.60)	2.49 (1.94-3.11)	0.371
UA (μmol/L)	308 (235-370)	372 (302-436)	0.011
FBG (mmol/L)	7.4 (5.7-9.6)	7.1 (5.6-9.4)	0.606
FCP (nmol/L)	0.39 (0.26-0.61)	0.66 (0.47-0.96)	<0.001
PCP (nmol/L)	0.93 (0.58-1.23)	1.55 (0.97-2.13)	<0.001
UCPCR (nmol/mmol)	0.11 (0.08-0.15)	0.57 (0.37-1.14)	<0.001
A1C (%)	9.7 (7.5-12.0)	9.1 (7.5-10.9)	0.294
Complications
DN (%)	0	10 (9.0)	0.256
DR (%)	5 (20.0)	15 (13.5)	0.607
DPN (%)	9 (36.0)	35 (31.5)	0.666
Treatment (%)
Insulin/secretagogues	23 (92.0)	66 (59.5)	0.002

Data is median (interquartile range), unless otherwise stated. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; WL: waistline; TG: triglyceride; TC: total cholesterol; HDL-c: high-density lipoprotein-cholesterol; LDL-c: low-density lipoprotein-cholesterol; UA: uric acid; FBG: fasting blood glucose; FCP: fasting C-peptide; PCP: postprandial C-peptide; A1C: HbA1c; DN: diabetic nephropathy; DR: diabetic retinopathy; DPN: diabetic peripheral neuropath. Statistical significance.